바로가기메뉴

본문 바로가기 주메뉴 바로가기

A Case of Pulmonary Cryptococcosis in an Immunocompetent Male Patient Diagnosed by a Percutaneous Supraclavicular Lymph Node Biopsy

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2015, v.78 no.3, pp.276-280









  • Downloaded
  • Viewed

Abstract

Cryptococcal pneumonia usually occurs in immunocompromised patients with malignancy, acquired immune deficiency syndrome, organ transplantations, immunosuppressive chemotherapies, catheter insertion, or dialysis. It can be diagnosed by gaining tissues in lung parenchyma or detecting antigen in blood or bronchoalveolar lavage fluid. Here we report an immunocompetent 32-year-old male patient with diabetes mellitus diagnosed with cryptococcal pneumonia after a ultrasound-guided percutaneous supraclavicular lymph node core needle biopsy. We treated him with fluconazole at 400 mg/day for 9 months according to the guideline. This is the first case that cryptococcal pneumonia was diagnosed from a percutaneous lymph node biopsy in South Korea.

keywords
Cryptococcosis, Pneumonia, Lymph Nodes, Biopsy, Fine-Needle

Reference

1.

1. Chang WC., Tzao C., Hsu HH., Lee SC., Huang KL., Tung HJ. (2006), Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest, 129,333-40.

2.

2. Nadrous HF., Antonios VS., Terrell CL., Ryu JH. (2003), Pulmonary cryptococcosis in nonimmunocompromised patients. Chest, 124,2143-7.

3.

3. Nakamura S., Miyazaki Y., Higashiyama Y., Yanagihara K., Ohno H., Hirakata Y. (2005), Community acquired pneumonia (CAP) caused by Cryptococcus neoformans in a healthy individual. Scand J Infect Dis, 37,932-5.

4.

4. Chang YS., Chou KC., Wang PC., Yang HB., Chen CH. (2005), Primary pulmonary cryptococcosis presenting as endobronchial tumor with left upper lobe collapse. J Chin Med Assoc, 68, 33-6.

5.

5. Smith JA., Kauffman CA. (2012), Pulmonary fungal infections. Respirology, 17,913-26.

6.

6. Perfect JR., Dismukes WE., Dromer F., Goldman DL., Graybill JR., Hamill RJ. (2010), Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis, 50,291-322.

7.

7. Huang L., Crothers K. (2009), HIV-associated opportunistic pneumonias. Respirology, 14,474-85.

8.

8. Johannson KA., Huston SM., Mody CH., Davidson W. (2012), Cryptococcus gattii pneumonia. CMAJ, 184,1387-90.

9.

9. Thomas CJ., Lee JY., Conn LA., Bradley ME., Gillespie RW., Dill SR. (1998), Surveillance of cryptococcosis in Alabama, 1992- 1994. Ann Epidemiol, 8,212-6.

10.

10. Saag MS., Graybill RJ., Larsen RA., Pappas PG., Perfect JR., Powderly WG. (2000), Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis, 30,710-8.

11.

11. Fox DL., Muller NL. (2005), Pulmonary cryptococcosis in immunocompetent patients: CT findings in 12 patients. AJR Am J Roentgenol, 185,622-6.

12.

12. Lindell RM., Hartman TE., Nadrous HF., Ryu JH. (2005), Pulmonary cryptococcosis: CT findings in immunocompetent patients. Radiology, 236,326-31.

13.

13. Hung MS., Tsai YH., Lee CH., Yang CT. (2008), Pulmonary cryptococcosis: clinical, radiographical and serological markers of dissemination. Respirology, 13,247-51.

14.

14. Guy JP., Raza S., Bondi E., Rosen Y., Kim DS., Berger BJ. (2012), Cryptococcus pneumonia presenting in an immunocompetent host with pulmonary asbestosis: a case report. J Med Case Rep, 6,170.

Tuberculosis & Respiratory Diseases